chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; chest was tight; fever of 99.5; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), CHEST DISCOMFORT (chest was tight) and PYREXIA (fever of 99.5) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date and Angioplasty (Stent in his heart.).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm), CHEST DISCOMFORT (chest was tight) and PYREXIA (fever of 99.5). At the time of the report, VACCINATION SITE PAIN (sore arm), CHEST DISCOMFORT (chest was tight) and PYREXIA (fever of 99.5) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       patient is taking blood pressure and blood thinner medication as conmeds. no treatment proivided
I received my vaccine on 10/28/2022. On 01/17/2023 I woke up with a cough, fever, aches and pains and overall not feeling well. On 01/18/2022 I tested for Covid-19 and was positive for Covid-19. I contacted my doctor and was prescribed Paxlovid. Symptoms have subsided with minor coughing still present.
About 4 months after the 2nd dose, I started to feel fatigue and weakness.  If I am holding something in my hand, I would start to shake and can not hold objects.   I also feel that my legs were going to give out and I would fall.  When I try to pick things up from the floor, I am unable to stand back up.  These episodes would last 5-10 minutes and will occur about once a week.   I did consult with my doctor and I was asked to monitor my blood pressure and see if it was low.  I did complete blood work which came back normal.  I was referred to a neurologist  Dr. and I did numerous neurological tests and everything came back normal.   They are going to order an MRI which I have scheduled next week.  The neurologist has mentioned that all my tests came back normal and there is no explanations as to where my symptoms are coming from except a possibilty from the vaccine.
Patient reported feeling dizzy and having a headache. She also reported a metallic taste in her mouth. Staff provided her with water to drink and monitored vital signs. Patient recovered and was released at 11:09 AM.
Information has been received from a consumer concerning her approximately 12 month old son with no known allergies or pertinent medical history who, 6 1/2 years ago, in approximately March 2000, was vaccinated with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. There was no concomitant medication. Subsequently, "around the same time" the vaccine was given, the patient started "showing signs" of autism. No tests were done, the patient was not hospitalized. At the time of the report the patient had not recovered. No further information was available. There was no product quality complaint involved. The patient's brother (WAES0609USA02487) also had an adverse experience after vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. Upon internal review, autism was considered to be an other important medical event (OMIC). Additional information has been requested.
Fever began on 9/3/19, seen in office 9/4/19 with conjunctivitis and right otitis media. He was prescribed a course of amoxicillin and instructed to recheck on 9/5/19. His mother brought him back in on 9/4/19 because he was not wanting to drink well. He was super fussy and still febrile. He had a rash on his trunk. His conjunctivae were injected bilaterally. His lips were red, dry, chapped and friable. He was admitted to the hospital on 9/4/19 under the care of the pediatric hospitalist. He was diagnosed with Kawasaki's on 9/9/19 via echocardiogram. He received IVIG and was discharged home on aspirin. He is being followed by Dr at the Clinic and a pediatric cardiologist, Dr.
Difficulty breathing because of swelling in mouth & throat 2-4 minutes after injection.  Rash/hives on face, neck, injection sight (left arm) and surrounding area.  I took 50 mg of Benadryl and it has kept the reaction from spreading.
Patient received Pfizer vaccine at 1310. At 1340, she complained of dizziness. Vitals: B/P 132/60, temp 97.3, heart rate 68, oxygen saturation 98%. Patient alert and oriented. 1405 patient stated dizziness is subsiding.
Menveo was given and had expired 10/31/2021.  No reaction to patient.  Called manufacturer and they do recommend revaccinating since expired greater than 30 days.  Mom made aware.
suffering searing pain from raw nerve endings, pain; This case was reported by a consumer via interactive digital media and described the occurrence of nerve pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine, the patient experienced nerve pain. On an unknown date, the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the nerve pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-SEP-2022 Reporter's comment: The patient self-reported this case via interactive digital media. The patient received doses both vaccines 4 years ago and was still suffering searing pain from raw nerve endings. The patient stated that he/she wished it was for weeks but over one year later he/she was still suffering searing pain from raw nerve endings. The patient also stated that his/her doctors still had not figured out to stop the pain. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Headache and weakness started within an hour. By midnight I had the chills and was shaking so bad it felt like a seizure, pressure in head increased, nausea and vomiting, very achy joints. Took Tylenol.
PATIENT REPORTS HIVES, REDNESS, ITCHING, AND SWELLING OF THE THROAT. PATIENT STATES SYMPTOMS RESOLVED AFTER TAKING BENADRYL
Developed double vision 4 days after 2nd Pfizer Covid vaccine.  Saw neurologist who diagnosed me with 6th nerve palsy.  Brain MRI was normal.
Intern reported after patient left the building that he noted a wet spot on the chair underneath where he administered the vaccine.  Intern also reported he thought he saw 1 drop of vaccine come out the side of syringe but that patient reported it felt like he received dose.  However, upon prompting, intern reports he does not believe patient received a full dose of Shingrix.  Patient stated it was his second shot for shingles, however, now I am wondering if patient was speaking to receiving Zostavax in the past.  We have tried calling patient several times but his voicemail box is full.  We will attempt to revaccinate him and establish if this is his first or second Shingrix dose.  Until patient responds, no adverse event per se to report, but an administration error.
Itching around injection site within a few hours which has persisted she also has an erythematous area which we are treating with antibiotics.
Morning after the vaccine, diarrhea started.  Would not stop for a week, and lost 5lb. 9 days after the vaccine, left arm turned bright red with shot administered location swollen.  Irregular period started with HEAVY bleeding.  Even with a pad on, the heavy bleeding was so bad that it bled through  whole left side of my jeans.
AFib; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in right arm, on 15Mar2021 at 14:00 (02:00 PM), at a single dose, for COVID-19 immunization. The patient had no medical history and concomitant medications. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. One week after the vaccine on 22Mar2021 at 09:00 AM, the patient had an atrial fibrillation (Afib) event. On 22Mar2021, the patient went to the emergency room (ER) or department or urgent care and ran tests including electrocardiogram (EKG), chest X-ray, and blood work which were all normal. Now, the patient had to go to a cardiologist for further understanding of the reason for AFib event. No treatment was given for the event. The patient has not been tested for COVID-19 post-vaccination. The patient was recovering from the event.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
patient came in to pharmacy to report she began to get pain in her left hip, groin, and ankle - and both knees about about 1 an 1/2 weeks after injection - left side is worse than right side
Patient called me on Monday 08/27/18 about the adverse event. She stated that in the evening of the day she received the shot, she started to have from the injection site down all the way to the elbow and inner arm redness and swelling. She had no pain but that her arm felt heavy. She had mentioned it started Saturday evening and continued into Sunday. She had not taken anything for the condition.
Pneumococcal sepsis with respiratory failure, altered mental status, cardiovascular shock, intubated x5 days. Now off pressors and doing better.
80-year-old male, who has a number of underlying comorbidities including COPD and renal insufficiency.  He was admitted to Hospital after a positive COVID test.  He had developed some generalized malaise with myalgias, headache, cough, and loose stool 5 days ago, which had been getting worse and presented for COVID testing after he was recently exposed to multiple sick family members.  He has been previously vaccinated.  On admission, he had a low-grade fever of 99.3 degrees Fahrenheit.  Chest x-ray showed patchy bibasilar interstitial and airspace opacities consistent with an atypical pneumonia.  His COVID-19 point of care test was positive.  His initial CBC showed a white blood cell count of 5.3, hemoglobin of 11.6 and platelet count of 229,000.  He initially was able to maintain normal oxygen saturation on room air, but has since required 2 L of supplemental oxygen for worsening hypoxia. Patient was treated with Remdesivir and Decadron. The patient was discharge on 8/30/2021, but was readmitted on 9/5/2021 for worsening symptoms secondary to bacterial pneumonia.
Vaccinated twice with Moderna. Both times I had an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Vaccinated twice with Moderna. Both times I had an allergic reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Vaccinated twice with Moderna. Both times I had an allergic reaction). At the time of the report, ALLERGY TO VACCINE (Vaccinated twice with Moderna. Both times I had an allergic reaction) outcome was unknown.            No concomitant medication was provided.  No treatment medication was provided.   This case was linked to MOD-2021-315269 (Patient Link).   Reporter did not allow further contact
PATIENT STILL HAS A RED TENDER SPOT WHERE THE VACCINE WAS ADMINSTERED. ABOUT AN INCH IN DIAMETER.
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 06-OCT-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L018499; expiry: 25-FEB-2017 (dose, route and frequency unspecified). No adverse effect was reported. This is one of the several reports received from the same source. Additional information has been requested.
COVID-19 positive. Received monoclonal antibodies. Symptom free in a week, tested negative 9 days after testing positive
Per provider's note:  1 /2/2021 and about 1.5 weeks after she started to notice some tingling of her right lower eyelid. It then started to feel like it was asleep. This lasts for about 10 minutes. It would go away and then come back about 2-3 weeks later. It would come and go and this week she noticed it was every day.
One hour after vaccination, pt reports "feeling out of it" and confused. Diarrhea began the following day. ON day 3, Monday, pt to ED c/o focal tremors intermittently in each arm and leg. Pt has no history of seizure disorder. On arrival to ED, pt having tremors in right arm, improved after benzodiazepine administration (ativan IV 1mg once). CT head negative for acute illness.
No further adverse effect reported; patient received a dose of improperly stored ROTATEQ; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's medical history, concomitant medications and concurrent conditions was provided.  On 24-FEB-2020, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 dose, lot # S014947, expiration date 10-DEC-2020 (route of administration not provided) for prophylaxis. No further adverse effect reported.  Digital Data logger was involved. The vaccine was stored at the temperature below 36 degrees of F (34 degrees of F), the time frame reported as 27 minutes. There was no previous temperature excursion reported.
Symptoms had mostly subsided on or after January 27  Symptoms included fever, chills, whole body aches, and fatigue
Next day post vax, the pt developed a generalized bright red macular rash over entire torso, groin/buttocks and upper legs. Given Benadryl with resolution within 2 hours.
Received Tdap 12/11/06 - no symptoms until 12/12/06 redness and soreness noted. Mother state she also had small amount of pus-like drainage then symptoms have improved everyday 12/15/06 today redness with soreness - measuring 45 x 45 mm.
ED visit for cellulitis of left lower extremity - treated in ED. Hospital admission for same problem - He was started on Zosyn and vancomycin and did have significant improvement in the erythema. He does have consultation that occurred with wound care and they did recommended Betadine treatments and follow-up with podiatry as well. After 2 days he was doing seem improved lab indices were appropriate and the cellulitis and signal improved on the IV course. He will now be transition to an outpatient infusion based treatments regimen. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Initial headache and body ache occuring same day of vaccination. Above issue disappeared within 3 days.   Day 4-5 post vaccination, headaches at random intervals began. Headache comes behind one eye and stays for 10-20 seconds, no longer than 30 seconds each time. The ache will then move to a new place, back of head, behind other eye, middle of cheek, and will stay only for 10-20 seconds. This happens multiple times per hour.   Chest pain in mid-chest. Like above pain, will happen for 10-20 seconds and stop. The pain is dull, not sharp. It returns on the other side with the same duration. This happens multiple times per hour.  Sometimes it feels like I'm struggling to stay standing and need to sit down or I may pass out.
This spontaneous report was received from a nurse practitioner refers to a 17 years old patient who on04-SEP-2012, was vaccinated subcutaneously with a dose of M-M-R II subcutaneously (Lot number: 0234AE, expiry date: 26-JAN-2014, Lot number: 1003AA, expiry date: 28-JUN-2013) that was stored at 47 Fahrenheit for 13 hours. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Hx malignant Carinoid tumor of the Bronchus; Lung-Hx of Respiratory Failure; This is a spontaneous report from a contactable nurse. An 89-year-old female non-pregnant patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 89-years-old intramuscular, administered in Arm Left on 09Sep2021 11:00 (Lot Number: 301358A) as single dose for covid-19 immunisation.  Medical history included failure to thrive. No known allergies. No COVID prior vaccination. No COVID tested post vaccination. No other vaccine in four weeks. Concomitant medication(s) included alprazolam; ondansetron; clarithromycin (CLARITIN); clopidogrel; sennoside a+b (SENNA); albuterol sulfate.  It was reported resident expired 24 hours after COVID vaccination, death causes were hx malignant carinoid tumor of the bronchus, lung-hx of respiratory failure. The adverse event start date and time was reported as 10Sep2021 14:45. No treatment was received. The patient died on 10Sep2021.  An autopsy was not performed.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events Carcinoid tumor pulmonary (fatal) Respiratory failure (Fatal) and BNT162B2.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate. ; Reported Cause(s) of Death: Lung-Hx Of Respiratory Failure; Hx malignant Carinoid tumor of the Bronchus
RECIEVED MODERNA ON 2/7/2021 THEN RECEIVED J&J ON 5/3/2021.
pt recvd vax & devel hives w/itching which persisted for 1 wk; No further details were provided;
Patient got dizzy, 30-60 minutes after school while out shopping. Felt unsteady, mother gave her OTC prevacid, Gatorade and sugar. She denies being dehydrated or skipping breakfast that am, symptoms resolved in 2 hours.
Pfizer-BioNTech COVID-19 Vaccine EUA:   About 15 minutes after receiving shot during my post-shot wait time in the store, I noticed the taste of metal in my mouth, it started from the back right and swept over it to the left and over my tongue (it was weirdly specific and noticeable).  It wasn't crazy strong, but it was distinctly a metal taste.  It kind of went away for a bit, but kept coming back intermittently throughout the day.  It's been two weeks and it still happens a little, but now mostly my sense of taste is messed up. Feels like on certain parts of my tongue things either don't taste right or I can't taste them at all.  Hoping it goes away eventually as  I REALLY love food. And coffee.
FEELING WAY MORE ACHE AND SORE; BURNING SENSATION IN ARMS; CRAMPY LEGS; CANT GET MOVING; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 05-SEP-2021, the patient experienced tired. On 06-SEP-2021, the patient experienced feeling way more ache and sore. On 06-SEP-2021, the patient experienced burning sensation in arms. On 06-SEP-2021, the patient experienced crampy legs. On 06-SEP-2021, the patient experienced cant get moving. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling way more ache and sore, and the outcome of tired, burning sensation in arms, crampy legs and cant get moving was not reported. This report was non-serious.
Because of what pediatrician believes about a potential connection between MMR and COVID, he, his wife, and his personal physician all recently vaccinated themselves with MMR II for protection against COVID-19.; This spontaneous report was received from a retired pediatrician, referring to a his wife, female patient of unspecified age. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported.   Because of what the reporting pediatrician believed was a potential connection between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) and coronavirus (COVID-19), he, his physician (captured in cases 2008USA008655 and 2008USA008539 respectively) and his wife all vaccinated themselves with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) for protection against COVID-19 on an unspecified date in 2020 (reported as "recently")  This is one of three reports received from the same reporter.; Sender's Comments:  US-009507513-2008USA008539: US-009507513-2008USA008655:
Several hours after vaccine, I become dizzy/light headed. I took blood pressure and it was 92/56.    I took 50 mg of Benadryl and the blood pressure came back up. Over the next several hours blood pressure remained low and a subsequent 50 mg of Benadryl was taken and finally blood pressure was up to 112/72.
red spot on the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red spot on the site of the injection) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included AMLODIPINE BESILATE (NORVASC) for Blood pressure high, ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red spot on the site of the injection). At the time of the report, VACCINATION SITE ERYTHEMA (red spot on the site of the injection) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Other concomitant medication included  Solcore 5mg once a day& acid reflux medicine.  No treatment medication was reported for 1st dose.   This case was linked to MOD-2021-244804 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Information received contains Non-Significant information On 23-Aug-2021: Information received contains non-significant information
Pain in face; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Pain in face) and HEADACHE (Headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced FACIAL PAIN (Pain in face) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FACIAL PAIN (Pain in face) and HEADACHE (Headache) outcome was unknown.            No concomitant medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.